Keywords: Acetazolamide, Antiobesity Agent, Atypical Antipsychotic Agent, Carbonate Dehydratase, Carbonate Dehydratase Ii, Carbonate Dehydratase Inhibitor, Diclofenamide, Ethoxzolamide, Methazolamide, Placebo, Sulfonamide, Topiramate, Trifluoromethanesulfonamide, Unclassified Drug, Zonisamide, Adjuvant Therapy, Bipolar Disorder, Clinical Trial, Cytosol, Disorders Of Acid Base Balance, Drug Dose Increase, Drug Dose Reduction, Drug Mechanism, Drug Protein Binding, Drug Structure, Drug Synthesis, Drug Tolerability, Enzyme Activity, Enzyme Inhibition, Epilepsy, Glaucoma, Human, Lipogenesis, Low Calory Diet, Mitochondrion, Neurologic Disease, Nonhuman, Pathophysiology, Review, Schizophrenia, Side Effect, Structure Activity Relation, Unspecified Side Effect, Weight Gain, Weight Reduction, X Ray Crystallography, Anti-Obesity Agents, Carbonic Anhydrase Inhibitors, Fructose, Isoxazoles,
Affiliations: *** IBB - CNR ***
Istituto di Biostructure e Bioimmagini-CNR, via Mezzocannone 16, 80134 Naples, Italy
Università degli Studi di Firenze, Laboratorio di Chimica Bioinorganica, Rm. 188, Via della Lastruccia 3, I-50019 Sesto Fiorentino, Firenze, Italy
Universit degli Studi di Firenze, Laboratorio di Chimica Bioinorganica, Rm. 188, Via della Lastruccia 3, I-50019 Sesto Fiorentino, Firenze, Italy